The same doctors who used that drug for the first time in the world are now testing another drug to help people who suffer a ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company’s ...

A stroke is an injury to the brain caused by an interruption in blood flow from a vessel blockage, blood clot or vessel ...

The other most common type of stroke is the Ischemic stroke that occurs when there is a blood clot or something that blocks ...

Bloodletting therapy at well points is thought to promote microcirculation and peripheral blood flow, effectively redirecting the body’s heat outward and enhancing the brain’s oxygen supply, which is ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

empagliflozin and ertugliflozin are approved by the FDA for the treatment of Type 2 diabetes. To analyze the impact of these two classes of medications, this study reviewed medical records for more ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

“Advancement of endovascular treatment allows these clots to be removed from the brain using ... “Patients who have have a ...

The study demonstrated that mechanical thrombectomy is a safe and effective method for stroke patients in India, achieving ...